SARS-CoV-2 Mpro-IN-47
SARS-CoV-2 Mpro-IN-47 is an orally active SARS-CoV-2 Mpro reversible covalent Inhibitor. SARS-CoV-2 Mpro-IN-47 shows potent antiviral activity against several clinical variants of SARS-CoV-2. SARS-CoV-2 Mpro-IN-47 can be used for the research of infection, such as SARS-CoV-2[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(N[C@H](C(C(NC1CC1)=O)=O)C[C@H]2C(NCCC2)=O)[C@H](CC3CCC3)C(C)C([C@@H](C4CCCC4)NC(C(C)(C)C)=O)=O
Molecular Formula
C33H52N4O6
Molecular Weight
600.79
References & Citations
[1]Tan QW, et al. Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity. J Med Chem. 2025 Aug 28;68 (16) :17087-17102.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
